{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:33:24Z","timestamp":1791318804159,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.08.016","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T05:16:23Z","timestamp":1408511783000},"page":"5681-5689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"32","author":[{"given":"Giuseppe","family":"Cappellano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiy Demeke","family":"Woldetsadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Orilieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Shivakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Carniato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casimiro Luca","family":"Gigliotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Boggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nausicaa","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristoforo","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Dianzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Boldorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Chiocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Ren\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Dianzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.08.016_bib0005","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nm0305-252","article-title":"Multiple sclerosis: trapped in deadly glue","volume":"11","author":"Platten","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0010","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/ni1318","article-title":"An intersection between the self-reactive regulatory and non regulatory T cell receptor repertoires","volume":"7","author":"Hsieh","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0015","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/intimm\/dxh029","article-title":"IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells","volume":"16","author":"Zhang","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0020","doi-asserted-by":"publisher","first-page":"6526","DOI":"10.4049\/jimmunol.173.11.6526","article-title":"Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells","volume":"173","author":"Huber","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0025","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/ni760","article-title":"Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4","volume":"3","author":"Chang","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0030","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.4049\/jimmunol.1000288","article-title":"TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10","volume":"184","author":"Huss","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0035","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","article-title":"IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis","volume":"185","author":"Yan","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0040","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.0105-2896.2006.00421.x","article-title":"Regulatory T cell physiology and application to treat autoimmunity","volume":"212","author":"Tang","year":"2005","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0045","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.anai.2011.05.017","article-title":"Specific immunotherapy and turning off the T cell: how does it work?","volume":"107","author":"Ozdemir","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0050","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jns.2008.05.021","article-title":"Antigen-specific therapies in MS \u2013 current concepts and novel approaches","volume":"274","author":"Lutterotti","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0055","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.clim.2012.05.010","article-title":"Immune modulating peptides for the treatment and suppression of multiple sclerosis","volume":"144","author":"Badawi","year":"2012","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0060","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0165-5728(86)90053-6","article-title":"Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis","volume":"13","author":"Johnson","year":"1986","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0065","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jaut.2006.12.002","article-title":"Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities","volume":"27","author":"Smith","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0070","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2249.1997.4251326.x","article-title":"Intracerebral injection of myelin basic protein (MBP) induces inflammation in brain and causes paraplegia in MBP-sensitized B6 mice","volume":"109","author":"Tsai","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0075","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/(SICI)1097-4547(19960815)45:4<410::AID-JNR10>3.0.CO;2-4","article-title":"Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide","volume":"45","author":"Karpus","year":"1996","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0080","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0165-5728(97)00019-2","article-title":"Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide","volume":"75","author":"Devaux","year":"1997","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0085","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.4049\/jimmunol.175.9.6226","article-title":"A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail\/IL-4-tolerizing DNA vaccination and treats autoimmune disease","volume":"175","author":"Ho","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0090","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2796.2010.02224.x","article-title":"Inverse vaccination, the opposite of Jenner's concept, for therapy of autoimmunity","volume":"267","author":"Steinman","year":"2010","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0095","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/archneur.64.10.nct70002","article-title":"Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1\/2 trial","volume":"64","author":"Bar-Or","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0100","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/ana.21370","article-title":"Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis","volume":"63","author":"Garren","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0105","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1002\/jps.21176","article-title":"Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms","volume":"97","author":"Houchin","year":"2008","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0110","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.addr.2004.09.003","article-title":"Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens","volume":"57","author":"Jiang","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0115","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/adhm.201200268","article-title":"Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective","volume":"2","author":"Leleux","year":"2013","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0120","doi-asserted-by":"publisher","first-page":"e26684","DOI":"10.1371\/journal.pone.0026684","article-title":"PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity","volume":"6","author":"Keijzer","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0125","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/nbt.2434","article-title":"Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis","volume":"30","author":"Getts","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0130","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ejpb.2007.09.006","article-title":"Controlled release of PEI\/DNA complexes from PLGA microspheres as a potent delivery system to enhance immune response to HIV vaccine DNA prime\/MVA boost regime","volume":"68","author":"Zhou","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0135","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1093\/intimm\/dxn016","article-title":"CD4+ICOS+ T lymphocytes inhibit T cell activation \u2018in vitro\u2019 and attenuate autoimmune encephalitis \u2018in vivo\u2019","volume":"20","author":"Rojo","year":"2008","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0140","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1742-2094-9-139","article-title":"Treatment with MOG-DNA vaccines induces CD4+CD25+FoxP3+ regulatory T cells and up-regulates genes with neuroprotective functions in experimental autoimmune encephalomyelitis","volume":"9","author":"Fissolo","year":"2012","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0145","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.nano.2010.02.002","article-title":"In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems","volume":"6","author":"Semete","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0150","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.intimp.2011.05.014","article-title":"The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response","volume":"11","author":"Nicolete","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0155","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.biomaterials.2013.10.046","article-title":"The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus","volume":"35","author":"Look","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0160","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1073\/pnas.0804897106","article-title":"Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome","volume":"106","author":"Sharp","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0165","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO;2-V","article-title":"IL-10 fails to abrogate experimental autoimmune encephalomyelitis","volume":"45","author":"Cannella","year":"1996","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0170","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1021\/mp4005172","article-title":"Treatment of experimental autoimmune encephalomyelitis by codelivery of disease associated peptide and dexamethasone in acetalated dextran microparticles","volume":"11","author":"Peine","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0175","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/80516","article-title":"Encephalitogenic potential of the myelin basic protein peptide (aa 83\u201399) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand","volume":"6","author":"Bielekova","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0180","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/jmcb\/mjt026","article-title":"Phenotypic and functional characteristic of a newly identified CD8+Foxp3\u2212CD103+ regulatory T cells","volume":"6","author":"Liu","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0185","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1002\/eji.200939441","article-title":"Novel CD8+ Treg suppress EAE by TGF-beta- and IFN-gamma-dependent mechanisms","volume":"39","author":"Chen","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0190","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1165\/rcmb.2012-0387OC","article-title":"Size-dependent uptake of particles by pulmonary antigen-presenting cell populations and trafficking to regional lymph nodes","volume":"49","author":"Blank","year":"2013","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0195","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/nature11337","article-title":"T cells become licensed in the lung to enter the central nervous system","volume":"488","author":"Odoardi","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0200","doi-asserted-by":"publisher","first-page":"188ra75","DOI":"10.1126\/scitranslmed.3006168","article-title":"Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis","volume":"5","author":"Lutterotti","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2014.08.016_bib0205","doi-asserted-by":"publisher","first-page":"e27860","DOI":"10.1371\/journal.pone.0027860","article-title":"\u2018Multi-epitope targeted\u2019 immune-specific therapy for a multiple sclerosis-like disease via engineered multi-epitope protein is superior to peptides","volume":"6","author":"Kaushansky","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14011293?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14011293?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T08:24:25Z","timestamp":1538295865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14011293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":41,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14011293"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.016","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}